Cormorant Global Healthcare Master Fund, LP, 10% Owner at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 700,000 shares at $18.36 ($14.0M) on 2024-09-20, disclosed to the SEC on 2024-09-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.48 | 45,085 | $788K | 5.6% |
| 2 | $17.48 | 45,085 | $788K | 5.6% |
| 3 | $18.36 | 25,943 | $476K | 3.4% |
| 4 | $18.36 | 25,943 | $476K | 3.4% |
| 5 | $19.61 | 66,088 | $1.3M | 9.3% |
| 6 | $19.61 | 66,088 |
| $1.3M |
| 9.3% |
| 7 | $20.42 | 139,551 | $2.8M | 20.3% |
| 8 | $20.42 | 139,551 | $2.8M | 20.3% |
| 9 | $21.47 | 47,564 | $1.0M | 7.3% |
| 10 | $21.47 | 47,564 | $1.0M | 7.3% |
| 11 | $22.23 | 25,769 | $573K | 4.1% |
| 12 | $22.23 | 25,769 | $573K | 4.1% |
| Total | $20.01 avg | 700,000 | $14.0M | 100% |
| Filing → |
| DRUG | BUY | 2024-10-17 | $6.4M | — | Filing → |
| EYPT | BUY | 2024-04-22 | $21.0M | — | Filing → |
| IMRX | SELL | 2024-03-18 | $4.6M | — | Filing → |